Skip to content

To see the Clinical Evaluation of Swarnakshiri Taila for the Management of Dushta Vrana (Chronic Wounds)

CLINICAL STUDY TO EVALUATE THE EFFICACY OF SWARNAKSHIRI TAILA IN THE MANAGEMENT OF DUSHTA VRANA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107494
Enrollment
30
Registered
2026-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Chandra Shekhar Singh Ayurved Chikitsalaya evam Shodh Kedra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Chronic non-healing ulcers and traumatic ulcers. 5 6 Diabetic foot ulcers, venous ulcers and bed sores. Clinically diagnosed cases of DushtaVrana (Chronic non-healing ulcers) as per Ayurveda (Acharya Sushruta) with lakshan of DushtaVrana. Willingness to participate and sign informed consent.

Exclusion criteria

Exclusion criteria: Patients not willing to undergo trail or not ready to give informed and written consent. Diabetic wound having uncontrolled diabetes (HbA1c more than 10) Malignant wound, leprosy, Gangrene. Immunocompromised patients (e.g., HIV, TB) and any other systematic disease. Patients on immunosuppressive therapy. Osteomyelitis patient.

Design outcomes

Primary

MeasureTime frame
Assessment of dusta Varna Under Subjective Parameter and Objective Parameters. Subjective Parameter- 1. Vedana (Pain) 2. Daha (Burnig Sensation) 3. Kandu (Itching) 4. Gandha (Foul odour) 5. Vrana Varna (Discolouration of wound Objective Parameters- 1. Vrana Parimana (wound size in length) 2. Discharge (srava) 3. Granulation tissue (Mamsautpatti)Timepoint: 3 months

Secondary

MeasureTime frame
Pain (VAS score), wound size reduction (cm ), discharge (grading), granulation tissue formation, foul smell, inflammation (clinical grading), & time to complete healing assessed at baseline & weekly till end of study.Timepoint: 60 days

Countries

India

Contacts

Public ContactProf. Dr. Chhayakantra Dash

Chandra Shekhar Singh Ayurvedic Sansthan

yahiyasalamay55@gmail.com8419807187

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026